Azintuxizumab vedotin Antibody
Azintuxizumab vedotin (ABBV-838) is an antibody-drug conjugate designed to target the CD2 subset 1 antigen on multiple myeloma cells. It facilitates research into ADC mechanisms and has been evaluated in preclinical in vitro and in vivo models for its therapeutic potential against hematological malignancies.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Immunology/Inflammation related
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.59 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog